Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katie M Stiles

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Virology|September 10, 2010
Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competitionKatie M Stiles, J Charles Whitbeck, Huan Lou, et al.
Leukemia|September 21, 2021
Gene therapy in a murine model of chronic eosinophilic leukemia-not otherwise specified (CEL-NOS)Odelya E Pagovich, Katie M Stiles, Anna E Camilleri, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 7, 2019
Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung DiseaseKatie M Stiles, Dolan Sondhi, Stephen M Kaminsky, et al.
Allergy|March 22, 2021
Gene therapy for a murine model of eosinophilic esophagitisAnna E Camilleri, Saparja Nag, Anthony R Russo, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2019
Gene Therapy Correction of Aldehyde Dehydrogenase 2 DeficiencyYuki Matsumura, Katie M Stiles, Jasmine Reid, et al.
Human Gene Therapy|December 6, 2019
Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol IngestionYuki Matsumura, Na Li, Hanan Alwaseem, et al.
JBMR Plus|April 17, 2023
Gene Therapy to Treat Osteopenia Associated With Chronic Ethanol Consumption and Aldehyde Dehydrogenase 2 DeficiencyAnna E Camilleri, Michelle Cung, Fiona M Hart, et al.
JCI Insight|August 8, 2020
Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsinMeredith L Sosulski, Katie M Stiles, Esther Z Frenk, et al.
Mutagenesis|October 21, 2005
The ATPase motif in RAD51D is required for resistance to DNA interstrand crosslinking agents and interaction with RAD51CAaron M Gruver, Kristi A Miller, Changanamkandath Rajesh, et al.
Human Gene Therapy|July 11, 2020
Stress-Induced Mouse Model of the Cardiac Manifestations of Friedreich's Ataxia Corrected by AAV-mediated Gene TherapyChristiana O Salami, Katie Jackson, Clarisse Jose, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Virology|September 10, 2010
Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competitionKatie M Stiles, J Charles Whitbeck, Huan Lou, et al.
Leukemia|September 21, 2021
Gene therapy in a murine model of chronic eosinophilic leukemia-not otherwise specified (CEL-NOS)Odelya E Pagovich, Katie M Stiles, Anna E Camilleri, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 7, 2019
Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung DiseaseKatie M Stiles, Dolan Sondhi, Stephen M Kaminsky, et al.
Allergy|March 22, 2021
Gene therapy for a murine model of eosinophilic esophagitisAnna E Camilleri, Saparja Nag, Anthony R Russo, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2019
Gene Therapy Correction of Aldehyde Dehydrogenase 2 DeficiencyYuki Matsumura, Katie M Stiles, Jasmine Reid, et al.
Human Gene Therapy|December 6, 2019
Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol IngestionYuki Matsumura, Na Li, Hanan Alwaseem, et al.
JBMR Plus|April 17, 2023
Gene Therapy to Treat Osteopenia Associated With Chronic Ethanol Consumption and Aldehyde Dehydrogenase 2 DeficiencyAnna E Camilleri, Michelle Cung, Fiona M Hart, et al.
JCI Insight|August 8, 2020
Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsinMeredith L Sosulski, Katie M Stiles, Esther Z Frenk, et al.
Mutagenesis|October 21, 2005
The ATPase motif in RAD51D is required for resistance to DNA interstrand crosslinking agents and interaction with RAD51CAaron M Gruver, Kristi A Miller, Changanamkandath Rajesh, et al.
Human Gene Therapy|July 11, 2020
Stress-Induced Mouse Model of the Cardiac Manifestations of Friedreich's Ataxia Corrected by AAV-mediated Gene TherapyChristiana O Salami, Katie Jackson, Clarisse Jose, et al.
Pageof 3